Amanote Research
Register
Sign In
Treatment of Anticonvulsant Osteomalacia With 1 Alpha Hydroxycholecalciferol.
BMJ
doi 10.1136/bmj.1.6060.551
Full Text
Open PDF
Abstract
Available in
full text
Date
February 26, 1977
Authors
J R Juttmann
J D Barth
J C Birkenhager
Publisher
BMJ
Related search
1-Alpha-Hydroxycholecalciferol for Renal Osteodystrophy.
BMJ
Treatment of Osteomalacia Associated With Primary Biliary Cirrhosis With Oral 1-Alpha-Hydroxy Vitamin D3.
BMJ
Letter: Anticonvulsant Osteomalacia and Vitamin D.
BMJ
I Alpha-Hydroxycholecalciferol: A Treatment of Renal Bone Disease.
BMJ
Safety and Efficacy of Alpha-1-Antitrypsin Augmentation Therapy in the Treatment of Patients With Alpha-1-Antitrypsin Deficiency
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Orphan Designation: Alpha-1 Antitrypsin (Inhalation Use), Treatment of Emphysema Secondary to Congenital Alpha-1-Antitrypsin Deficiency
Case Medical Research
Dietary Calcium Levels Reduce the Efficacy of One Alpha-Hydroxycholecalciferol in Phosphorus-Deficient Diets of Broilers
Journal of Poultry Science
Animal Science
Zoology
Surgical Treatment of Tumor-Induced Osteomalacia: A Retrospective Review of 40 Cases With Extremity Tumors
BMC Musculoskeletal Disorders
Rheumatology
Orthopedics
Sports Medicine
Tumor-Induced Osteomalacia
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes